The coronavirus pandemic has dominated the headlines and our daily lives for most of this year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask.
However, this has not stopped us from publishing hundreds of fascinating stories on a myriad of other topics.
This week, we reported on the long-term cognitive benefits of playing video games (nobody tell my 12-year-old), the link between thunderstorms and an increased number of emergency room visits, and how simple changes to your lifestyle and diet could ward off dementia.
We also look at a new light therapy for people with migraine, which has been tested in humans for the first time, and a study that saw stem cell implantation restore motor function in mice with Parkinsons disease.
Finally, we look at the psychology of voting (and not voting) and news from Germany about how even a gentle 10-minute massage can bring about lasting relaxation.
Below are 10 recent stories that you may have missed amid all the COVID-19 fervor.
Good news for gamers, this week, with our report on new research that has found a link between video games and cognition. The results suggest that video games may induce cognitive changes that last for years after people have stopped playing.
Video games are a perfect recipe for strengthening our cognitive skills, almost without our noticing, says the lead author of the study, Dr. Marc Palaus.
Learn more here.
Our detailed report on this extremely rare, very serious congenital condition was read by over 100,000 visitors this week, making it our most-viewed new article.
Mermaid syndrome, or sirenomelia, was first described in the medical literature of the 15th century. It is called mermaid syndrome because the newborn babys legs are fused. Our article looks at the causes, treatments, and care techniques, as well as possible risk factors and the outlook for babies with this syndrome.
Learn more here.
There was also great interest in our coverage of new research that may help both the diagnosis and treatment of Alzheimers disease. Nearly 4,000 readers spent, on average, over 6 minutes with this article.
Scientists at the Instituto de Neurociencias de Alicante, in Spain, identified differences in how the brains of people with Alzheimers chemically label a key protein, called the amyloid precursor protein, with sugars.
Finding this difference in the proteins sugar labeling, or glycosylation, could lead to the development of a new diagnostic test for Alzheimers disease. In the longer term, it may even inspire new treatments.
Learn more here.
This week, MNT reported on a possible link between weather conditions and the number of older adults visiting emergency rooms with respiratory issues. Over the 14-year period covered in their study, the researchers found 52,000 additional visits to emergency rooms on the days to either side of a significant thunderstorm.
Its thought that climate change will cause more intense thunderstorms of the type identified in this study. Respiratory problems spurred by an increase in temperature and particulate matter caused by storms could result in many more older people seeking medical assistance, particularly if they have asthma or chronic obstructive pulmonary disease.
Learn more here.
Changing the diet and increasing physical activity levels can reduce the risk of developing dementia, even in older people, after a diagnosis of cognitive decline. That was the conclusion of a proof-of-concept study covered by MNT this week.
The changes proposed in the new study, led by a team from The Australian National University, in Canberra, are relatively easy to adopt and inexpensive to follow, making this approach to preventing dementia a promising option for many older people.
With the right intervention, people experiencing cognitive decline may retain sufficient neuroplasticity for their brain to bounce back from decline, says Mitchell McMaster, the studys lead author.
Learn more here.
Migraine usually involves moderate-to-severe headaches, which may accompany other symptoms that can be debilitating, such as visual disturbances, nausea, vomiting, dizziness, and extreme sensitivity to sound and light.
Pain relief medications are not always effective and often cause unpleasant side effects. Light therapy, however, offers the promise of relief without a dependence upon drugs.
This week, MNT reported on new research that suggests that exposure to green light of a particular wavelength and brightness may relieve migraine headaches just as effectively as drugs.
The results have already been demonstrated in mice, and this new study represents the first time a clinical trial of green light therapy in humans has produced a significant improvement in the frequency of migraine headaches.
Learn more here.
In a fascinating study, covered this week by MNT, researches found that the type of neurons transplanted into the brain, rather than their location, was the key to restoring brain health and movement in mice with Parkinsons disease.
Within 45 months, the dopamine-producing stem cells implanted in this study made connections with the area of the brain involved in coordinating movement.
However, the researchers caution that the greater distances between brain areas in humans may make it more difficult for implanted stem cells to make these connections and restore movement in the same way.
Learn more here.
A diet of junk food in your teens and early 20s may contribute to serious health problems decades later, even if your diet improves in the meantime. This was the conclusion of new research that we covered this week.
The authors argue that this evidence supports the prescription of lipid-lowering drugs, like statins, in people aged 2039 years as well as earlier interventions to improve dietary and lifestyle choices if doctors detect high cholesterol.
Learn more here.
In recent weeks, MNT has published a number of articles on health and the 2020 election, covering topics like the mental health benefits of voting, advice on how to vote safely, and how health influences voting behavior.
In this Special Feature, we look at voter apathy and some of the factors that may influence the psychology of voting. We ask: Who votes, who does not, and why might this be?
Learn more here.
Finally in this weeks Recovery Room, weve found another reason to unwind with a massage. Psychologists at the University of Konstanz, in Germany, have found that a 10-minute massage measurably increases relaxation.
The researchers divided participants into three groups. One received a moderately intense 10-minute massage designed to activate the stress-relieving parasympathetic nervous system. The second group received a softer massage, and the third group was asked to sit at a table and relax for 10 minutes, no massage included.
All of the participants reported feeling less stressed and more relaxed after the tests, but heart rate variability (HRV), a physiological measure of relaxation, was much higher in those who had received a massage. The team now plans to measure the benefits of other relaxation techniques, such as meditation and breathing exercises, using HRV as their guide.
Learn more here.
We hope these have provided a taste of the stories that we cover at MNT. We will be back with a new selection next week.
We publish hundreds of news stories and features every month. Here are some upcoming articles that may pique our readers interest:
Link:
The Recovery Room: News beyond the pandemic October 2 - Medical News Today
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments